NanoGroup S.A. (WSE:NNG)

Market Cap	97.11M
Revenue (ttm)	2.10K
Net Income (ttm)	-5.17M
Shares Out	31.63M
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,605
Average Volume	45,476
Open	2.900
Previous Close	2.950
Day's Range	2.830 - 2.990
52-Week Range	0.892 - 4.370
Beta	1.27
RSI	51.65
Earnings Date	Apr 25, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Country: Poland
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NNG

Financial Performance

In 2024, NanoGroup's revenue was 2,100, an increase of 4.01% compared to the previous year's 2,019. Losses were -5.17 million, -34.50% less than in 2023.